Prof Jean-Charles Soria presents the most up-to-date data from 85 patients with non-small cell lung cancer in a large, phase I clinical trial of an experimental drug called MPDL3280A, during a press conference at the 2013 European Cancer Conference (ECC 2013).

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.

Read more on ecancerNews